Atara biotherapeutics to announce first quarter 2020 financial results on wednesday, may 6, 2020
South san francisco, calif.--(business wire)--atara biotherapeutics, inc. (nasdaq: atra), a leading off-the-shelf, allogeneic t-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced the company will release first quarter 2020 financial results after market close on wednesday, may 6, 2020. following the release, the company will host a live conference call and webcast at 4:30 p.m. edt to discuss the company’s financial results and provide a corporate update. analysts and investors can participate in the conference call by dialing (888) 540-6216 for domestic callers and (734) 385-2715 for international callers, using the conference id 5488522. a live audio webcast can be accessed by visiting the investors & media – news & events section of atarabio.com. an archived replay will be available on the company's website for 14 days following the live webcast. about atara biotherapeutics, inc. atara biotherapeutics, inc. (@atarabio) is a leading off-the-shelf, allogeneic t-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. atara’s technology platform leverages research collaborations with leading academic institutions with the company’s scientific, clinical, regulatory and manufacturing expertise. atara’s pipeline includes tab-cel® (tabelecleucel), which is in phase 3 development for patients with epstein-barr virus-associated post-transplant lymphoproliferative disease (ebv+ ptld) as well as in earlier stage development for other ebv-associated hematologic malignancies and solid tumors, including nasopharyngeal carcinoma (npc); t-cell immunotherapies targeting ebv antigens believed to be important for the potential treatment of multiple sclerosis; and next-generation chimeric antigen receptor t-cell (car t) immunotherapies. the company was founded in 2012 and is co-located in south san francisco and southern california. our southern california hub is anchored by its manufacturing facility in thousand oaks, california. for additional information about the company, please visit atarabio.com.
ATRA Ratings Summary
ATRA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission